[Industry Analysis] Daewoong Pharmaceutical's overseas business is expected to grow rapidly...Expectations for the global launch of two new drugs
상태바
[Industry Analysis] Daewoong Pharmaceutical's overseas business is expected to grow rapidly...Expectations for the global launch of two new drugs
  • BK Min
  • 승인 2022.11.25 12:33
  • 댓글 0
이 기사를 공유합니다

▶대웅제약, '신약 펙스클루' 글로벌 15개 국가 1조 2000억 원 규모 기술수출 계약 체결
▶해외 사업 고성장 전망
Daewoong Pharmaceutical, Expectations for the global launch of two new drugs

Daewoong Pharmaceutical's gastroesophageal reflux treatment (FEXUCLUE, expected to be sold in the fourth quarter of 2022) and diabetes treatment (enavogliflozin, expected to be released in the second half of 2023) are drugs with the latest mechanism of action, and the prescription rate in the related market is increasing.

Daewoong Pharmaceutical's products are expected to increase worldwide market share in a fast-growing market based on brand power and marketing power.

In addition, Nabota(botulinum toxin preparation) was concluded after the lawsuit between Medytox and Evolus, and Strong sales growth in the US market is expected to continue. Exports, which were around KRW 49 billion in 2021, increased to KRW 23 billion in the first quarter of 2022 alone. 

Daewoong Pharmaceutical plans to enlarge its established global market including China, Australia, and Europe.

The markets targeted by the new products (FEXUCLUE tablets, and Enavogliflozin) are gastric reflux treatment and type 2 diabetes treatment, which are valued at around US$ 150 million and US$ 526.6 million for each and are growing steadily in terms of chronic disease treatment.

In the same market, fexuclue tablets and Enavogliflozin are showing the effect of increasing efficacy and lowering side effects in areas where existing treatments have not met based on a new mechanism of action. Sales of each product are expected to exceed KRW 60 billion and KRW 40 billion, respectively, in the third year after launch.

by BK Min, KDFN kdf@kdfnews.com


관련기사
더보기+

주요기사
댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.